T1	Participants 33 56	acute coronary syndrome
T2	Participants 446 690	We performed a pilot, non-randomized, unblinded clinical trial that included 16 patients with acute coronary artery syndrome, a capillary or venous blood glucose â‰¥ 140 mg/dl, and treatment with a continuous infusion of fast acting human insulin
T3	Participants 698 737	patients were randomized into 2 groups:
T4	Participants 738 758	a conventional group
T5	Participants 859 880	an intervention group
